Vildagliptin / Metformin hydrochloride Accord Europeiska unionen - svenska - EMA (European Medicines Agency)

vildagliptin / metformin hydrochloride accord

accord healthcare s.l.u. - metformin hydrochloride, vildagliptin - diabetes mellitus, typ 2 - läkemedel som används vid diabetes - vildagliptin/metformin hydrochloride accord is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:- in patients who are inadequately controlled with metformin hydrochloride alone. - in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. - in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control (see sections 4. 4, 4. 5 och 5. 1 för tillgänglig data på olika kombinationer).

Metformin Rosemont 100 mg/ml Oral lösning Sverige - svenska - Läkemedelsverket (Medical Products Agency)

metformin rosemont 100 mg/ml oral lösning

rosemont pharmaceuticals ltd - metforminhydroklorid - oral lösning - 100 mg/ml - maltitol, flytande hjälpämne; natriumpropylparahydroxibensoat hjälpämne; natriummetylparahydroxibensoat hjälpämne; metforminhydroklorid 100 mg aktiv substans - metformin

Metformin GEA 500 mg Filmdragerad tablett Sverige - svenska - Läkemedelsverket (Medical Products Agency)

metformin gea 500 mg filmdragerad tablett

hexal a/s - metforminhydroklorid - filmdragerad tablett - 500 mg - propylenglykol hjälpämne; metforminhydroklorid 500 mg aktiv substans - metformin

Metformin Hexal 500 mg Filmdragerad tablett Sverige - svenska - Läkemedelsverket (Medical Products Agency)

metformin hexal 500 mg filmdragerad tablett

hexal a/s - metforminhydroklorid - filmdragerad tablett - 500 mg - laktosmonohydrat hjälpämne; metforminhydroklorid 500 mg aktiv substans - metformin

Metformin GEA 850 mg Filmdragerad tablett Sverige - svenska - Läkemedelsverket (Medical Products Agency)

metformin gea 850 mg filmdragerad tablett

hexal a/s - metforminhydroklorid - filmdragerad tablett - 850 mg - propylenglykol hjälpämne; metforminhydroklorid 850 mg aktiv substans - metformin

Metformin Hexal 850 mg Filmdragerad tablett Sverige - svenska - Läkemedelsverket (Medical Products Agency)

metformin hexal 850 mg filmdragerad tablett

hexal a/s - metforminhydroklorid - filmdragerad tablett - 850 mg - laktosmonohydrat hjälpämne; metforminhydroklorid 850 mg aktiv substans - metformin

Vildagliptin/Metformin Krka 50 mg/850 mg Filmdragerad tablett Sverige - svenska - Läkemedelsverket (Medical Products Agency)

vildagliptin/metformin krka 50 mg/850 mg filmdragerad tablett

krka d.d., novo mesto - metforminhydroklorid; vildagliptin - filmdragerad tablett - 50 mg/850 mg - propylenglykol hjälpämne; mannitol hjälpämne; vildagliptin 50 mg aktiv substans; metforminhydroklorid 850 mg aktiv substans

Sitagliptin/Metformin Grindeks 50 mg/850 mg Filmdragerad tablett Sverige - svenska - Läkemedelsverket (Medical Products Agency)

sitagliptin/metformin grindeks 50 mg/850 mg filmdragerad tablett

as grindeks - metforminhydroklorid; sitagliptinhydrokloridmonohydrat - filmdragerad tablett - 50 mg/850 mg - natriumlaurilsulfat hjälpämne; sitagliptinhydrokloridmonohydrat 56,68 mg aktiv substans; metforminhydroklorid 850 mg aktiv substans

Sitagliptin/Metformin Grindeks 50 mg/1000 mg Filmdragerad tablett Sverige - svenska - Läkemedelsverket (Medical Products Agency)

sitagliptin/metformin grindeks 50 mg/1000 mg filmdragerad tablett

as grindeks - metforminhydroklorid; sitagliptinhydrokloridmonohydrat - filmdragerad tablett - 50 mg/1000 mg - natriumlaurilsulfat hjälpämne; metforminhydroklorid 1000 mg aktiv substans; sitagliptinhydrokloridmonohydrat 56,68 mg aktiv substans

Sitagliptin / Metformin hydrochloride Accord Europeiska unionen - svenska - EMA (European Medicines Agency)

sitagliptin / metformin hydrochloride accord

accord healthcare s.l.u. - metformin hydrochloride, sitagliptin hydrochloride monohydrate - diabetes mellitus, typ 2 - läkemedel som används vid diabetes - for adult patients with type 2 diabetes mellitus:it is indicated as an adjunct to diet and exercise to improve glycaemic control in patients inadequately controlled on their maximal tolerated dose of metformin alone or those already being treated with the combination of sitagliptin and metformin. it is indicated in combination with a sulphonylurea (i. - , trippel kombinationsterapi) som ett komplement till kost och motion hos patienter bristfälligt kontrollerad på deras maximal tolererad dos av metformin och en sulphonylurea. it is indicated as triple combination therapy with a peroxisome proliferator-activated receptor gamma (pparγ) agonist (i. , a thiazolidinedione) as an adjunct to diet and exercise in patients inadequately controlled on their maximal tolerated dose of metformin and a pparγ agonist. it is also indicated as add-on to insulin (i. , triple combination therapy) as an adjunct to diet and exercise to improve glycaemic control in patients when stable dose of insulin and metformin alone do not provide adequate glycaemic control.